Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olfred Hansen

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2024
Cumulative rib fracture risk after stereotactic body radiotherapy in patients with localized non-small cell lung cancerKristian Kirkelund Bentsen, Carsten Brink, Tine Bjørn Nielsen, et al.
Acta Oncologica (Stockholm, Sweden)|September 20, 2014
Plan quality and delivery accuracy of flattening filter free beam for SBRT lung treatmentsChristian Rønn Hansen, Anders Bertelsen, Hans Lynggaard Riis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 25, 2016
Acute esophagitis for patients with local-regional advanced non small cell lung cancer treated with concurrent chemoradiotherapyYi Pan, Carsten Brink, Marianne Knap, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 17, 2017
Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT imagesJanna E van Timmeren, Ralph T H Leijenaar, Wouter van Elmpt, et al.
Lancet (London, England)|September 27, 2003
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trialJens Overgaard, Hanne Sand Hansen, Lena Specht, et al.
The Lancet. Oncology|March 9, 2016
Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trialChristina H Ruhlmann, Thomas Broe Christensen, Line Hammer Dohn, et al.
Acta Oncologica (Stockholm, Sweden)|November 7, 2023
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecanMorten Mau-Sørensen, Jonas Gerner-Rasmussen, Olfred Hansen, et al.
Acta Oncologica (Stockholm, Sweden)|June 10, 2015
Keratin 34betaE12/keratin7 expression is a prognostic factor of cancer-specific and overall survival in patients with early stage non-small cell lung cancerMette Pøhl, Karen Ege Olsen, Rene Holst, et al.
Clinical and Translational Radiation Oncology|January 1, 2021
Prospectively scored pulmonary toxicities in non-small cell lung cancer: Results from a randomized phase II dose escalation trialChristina M Lutz, Marianne M Knap, Lone Hoffmann, et al.
BMC Research Notes|October 21, 2011
Analytical variables influencing the performance of a miRNA based laboratory assay for prediction of relapse in stage I non-small cell lung cancer (NSCLC)Jesper Dahlgaard, Wiktor Mazin, Thomas Jensen, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2024
Cumulative rib fracture risk after stereotactic body radiotherapy in patients with localized non-small cell lung cancerKristian Kirkelund Bentsen, Carsten Brink, Tine Bjørn Nielsen, et al.
Acta Oncologica (Stockholm, Sweden)|September 20, 2014
Plan quality and delivery accuracy of flattening filter free beam for SBRT lung treatmentsChristian Rønn Hansen, Anders Bertelsen, Hans Lynggaard Riis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 25, 2016
Acute esophagitis for patients with local-regional advanced non small cell lung cancer treated with concurrent chemoradiotherapyYi Pan, Carsten Brink, Marianne Knap, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 17, 2017
Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT imagesJanna E van Timmeren, Ralph T H Leijenaar, Wouter van Elmpt, et al.
Lancet (London, England)|September 27, 2003
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trialJens Overgaard, Hanne Sand Hansen, Lena Specht, et al.
The Lancet. Oncology|March 9, 2016
Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trialChristina H Ruhlmann, Thomas Broe Christensen, Line Hammer Dohn, et al.
Acta Oncologica (Stockholm, Sweden)|November 7, 2023
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecanMorten Mau-Sørensen, Jonas Gerner-Rasmussen, Olfred Hansen, et al.
Acta Oncologica (Stockholm, Sweden)|June 10, 2015
Keratin 34betaE12/keratin7 expression is a prognostic factor of cancer-specific and overall survival in patients with early stage non-small cell lung cancerMette Pøhl, Karen Ege Olsen, Rene Holst, et al.
Clinical and Translational Radiation Oncology|January 1, 2021
Prospectively scored pulmonary toxicities in non-small cell lung cancer: Results from a randomized phase II dose escalation trialChristina M Lutz, Marianne M Knap, Lone Hoffmann, et al.
BMC Research Notes|October 21, 2011
Analytical variables influencing the performance of a miRNA based laboratory assay for prediction of relapse in stage I non-small cell lung cancer (NSCLC)Jesper Dahlgaard, Wiktor Mazin, Thomas Jensen, et al.
Pageof 9